Thomas Barrack, Jr. formed Colony Capital in 1990 as a 43 year with a diverse curriculum vitae. After graduating law school in 1972, Barrack joined the law firm of Herbert M. Kalmbach, then President Nixon’s personal attorney. (1/13)
Two months into his time working for Kalmbach, Barrack travelled to Saudi Arabia on behalf of the firm and its client, the construction company, Flour. (2/13)
After a chance meeting over a squash game, Barrack resigned from Kalmbach to work as a representative for a cadre Saudi Arabian princes. (3/13)
2/ Paul Vogel was promoted to CFO in late 2019, succeeding Barry McCarthy, who joined SPOT from Netflix, $NFLX, and spearheaded The Company's direct listing
During its first two years as a public company, SPOT developed credibility from their investors
1/ Dr. Matthew Walker claims, “…evidence that makes clear all of the dangers…when sleep becomes short have not been telegraphed to the public. It is the most glaring omission in the contemporary health conversation” in his 2017 book, Why We Sleep
2/ 2-9% of adults in the U.S. suffer from abnormal breathing during sleep, known as Obstructive Sleep Apnea (“OSA”). Heart attacks, strokes and other chronic conditions are highly correlated with OSA. Resmed, $RMD, is the leading provider of Sleep Apnea care products globally
3/ Resmed sells continuous positive airway pressure, “CPAP”, mask systems used to treat OSA and as well as ventilators and portable oxygen concentrators used to treat Chronic Obstructive Pulmonary Disease and other respiratory diseases
1/ In their 2019 paper, Complexity Investing, NZS suggests that, “products, services…can be optimized for RESILIENCE…cash generative businesses that...fund a series of OPTIONAL investments…”
2/ TMO uses cash generated from their resilient businesses, laboratory equipment, supplies and services as well as diagnostic instruments, and through a systemic M&A program, buys high optionality businesses serving the pharmaceutical industry
3/ The Company’s lineage begins with Fisher Scientific in 1902 and separately, Thermo Electron in 1956
By January 2004, Thermo finished simplifying their corporate structure, buying out minority shareholders of 22 subsidiaries spun out in the 1990s and divesting non-core assets